Table 11.
Substance | Origin | N | Ratio to morphinea | |||||
---|---|---|---|---|---|---|---|---|
Min | P25 | Median | P75 | P95b | Max | |||
Codeine | ‘High‐morphine’ | 142 | < 0.01 | 0.04 | 0.14 | 0.29 | 1.08 | 713 |
‘Low‐morphine’ | 1,086 | 0.01 | 0.10 | 0.14 | 0.20 | 0.51 | 0.97 | |
Unknown | 257 | 0.01 | 0.09 | 0.15 | 0.27 | 0.67 | 2.33 | |
Total | 1,485 | < 0.01 | 0.10 | 0.14 | 0.21 | 0.75 | 713 | |
Thebaine | ‘High‐morphine’ | 123 | 0.01 | 0.11 | 0.29 | 14.0 | 135 | 227 |
‘Low‐morphine’ | 936 | < 0.01 | 0.08 | 0.14 | 0.22 | 0.48 | 1.86 | |
Unknown | 143 | < 0.01 | 0.07 | 0.12 | 0.19 | 0.52 | 1.10 | |
Total | 1,202 | < 0.01 | 0.08 | 0.14 | 0.24 | 0.84 | 227 | |
Oripavine | ‘High‐morphine’ | 46 | < 0.01 | 0.01 | 0.87 | 4.34 | n.a. | 43.4 |
‘Low‐morphine’ | 15 | < 0.01 | 0.01 | 0.01 | 0.02 | n.a. | 0.47 | |
Unknown | 23 | < 0.01 | 0.01 | 0.02 | 0.05 | n.a. | 0.21 | |
Total | 84 | < 0.01 | 0.01 | 0.04 | 0.87 | 19.9 | 43.4 | |
Noscapine | ‘High‐morphine’ | 26 | < 0.01 | < 0.01 | < 0.01 | < 0.01 | n.a. | 0.75 |
‘Low‐morphine’ | 939 | < 0.01 | 0.04 | 0.07 | 0.14 | 0.62 | 6.75 | |
Unknown | 127 | < 0.01 | 0.01 | 0.05 | 0.09 | 0.23 | 0.48 | |
Total | 1,092 | < 0.01 | 0.03 | 0.07 | 0.13 | 0.57 | 6.75 | |
Papaverine | ‘High‐morphine’ | 26 | < 0.01 | < 0.01 | < 0.01 | < 0.01 | n.a. | 0.76 |
‘Low‐morphine’ | 272 | < 0.01 | 0.01 | 0.02 | 0.11 | 0.76 | 0.76 | |
Unknown | 87 | < 0.01 | < 0.01 | 0.01 | 0.05 | n.a. | 0.76 | |
Total | 385 | < 0.01 | 0.01 | 0.02 | 0.09 | 0.76 | 0.76 |
N: number of samples; n.a.: not applicable; Max: maximum; Min: minimum; P: percentile.
Calculated by dividing the opium alkaloid upper bound concentration by the morphine upper bound concentration. Concentrations were expressed as mmol/kg.
The 95th percentile with less than 60 observations may not be statistically robust (EFSA, 2011b) and is therefore not calculated.